Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photobiomodulation versus topical capsaicin for burning mouth syndrome
RBR-7pxxjzdCompleted
- Sponsor
- Universidade Federal do Rio Grande do Norte
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of capsaicin in glossodynia (BMS) (4 arms), sponsored by Universidade Federal do Rio Grande do Norte. Primary endpoint: Change in pain/burning symptom intensity. Started Jun 2024; status: completed.
02
Drugs
capsaicin
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on RBR-7pxxjzd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7pxxjzd.